Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage

被引:1
|
作者
Wasfy, Jason H. [1 ]
O'Kelly, Anna C. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA
关键词
cost-effectiveness; health policy; heart failure; GUIDELINES;
D O I
10.1016/j.jacc.2022.04.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2526 / 2528
页数:3
相关论文
共 41 条
  • [21] Could or Should We Use Cost-Effectiveness Thresholds in the French Value-Based Pricing Process for New Drugs?
    Ghabri, Salah
    PHARMACOECONOMICS, 2024, 42 (08) : 823 - 827
  • [22] Pediatric versus adult cardiomyopathy and heart failure related hospitalizations: A value-based analysis
    Wittlieb-Weber, Carol A.
    Lin, Kimberly Y.
    Zaoutis, Theoklis E.
    O'Connor, Matthew J.
    Paridon, Stephen M.
    Shaddy, Robert E.
    Rossano, Joseph W.
    Gerald, Ken
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2014, 37 (1-2) : 43 - 43
  • [23] EXPLORING THE CONTRIBUTION OF HEALTH GAINS AND COST-OFFSETS TO VALUE-BASED DRUG PRICES IN PRIOR ICER REVIEWS
    Richardson, M.
    Whittington, M.
    Moradi, A.
    Campbell, J.
    VALUE IN HEALTH, 2023, 26 (06) : S220 - S220
  • [24] Pediatric Versus Adult Cardiomyopathy and Heart Failure-Related Hospitalizations: A Value-Based Analysis
    Wittlieb-Weber, Carol A.
    Lin, Kimberly Y.
    Zaoutis, Theoklis E.
    O'Connor, Matthew J.
    Gerald, Ken
    Paridon, Stephen M.
    Shaddy, Robert E.
    Rossano, Joseph W.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (01) : 76 - 82
  • [25] Views of Patients With Heart Failure on Their Value-Based Self-care Decisions A Qualitative Study
    Karimi-Dehkordi, Mehri
    Clark, Alexander M.
    JOURNAL OF CARDIOVASCULAR NURSING, 2020, 35 (06) : E89 - E98
  • [26] Laboratory Value-Based Innovation in Heart Failure Improves Patient Health-Related Outcomes
    Leon-Justel, Antonio
    Morgado Garcia-Polavieja, Jose, I
    Isabel Alvarez-Rios, Ana
    Vazquez-Rico, Ignacio
    Lopez-Masjuan Rios, Alvaro
    Rodriguez Albarran, Adrian
    Galvez Rios, Elena
    Diaz Fernandez, Jose F.
    CLINICAL LABORATORY, 2022, 68 (02) : 261 - 270
  • [27] ANALYSIS OF DRUG UTILISATION DATA SOURCES TO ENABLE NATIONWIDE VALUE-BASED PRICING OF MEDICINES ACROSS HEALTHCARE SYSTEMS IN EUROPE
    Menner, J.
    Ruiz, Jimenez Md
    Lewandowska, P. K.
    VALUE IN HEALTH, 2017, 20 (09) : A702 - A703
  • [28] Cost-effectiveness analysis of an orphan drug tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing
    Luo, Shaohong
    Xie, Chen
    Lin, Ningning
    Lin, Dong
    Gu, Dian
    Lin, Shen
    Huang, Xiaoting
    Xu, Xiongwei
    Weng, Xiuhua
    MELANOMA RESEARCH, 2023, 33 (06) : 525 - 531
  • [29] Laboratory value-based innovation in heart failure can improve patient health-related outcomes
    Jose Ignacio, J. M. G. Morgado Garcia De Polavieja
    Justel Antonio, L. J. A. Leon
    Rios Alvaro, A. L. M. Lopez-Masjuan
    Albarran Adrian, A. R. A. Rodriguez
    Ana Isabel, A. A. R. Alvarez-Rios
    Jose F, J. F. D. Diaz Fernandez
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 97 - 98
  • [30] Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy A Cost-effectiveness Analysis
    Shaker, Marcus
    Greenhawt, Matthew
    JAMA NETWORK OPEN, 2018, 1 (07) : e184728